 Arecor Therapeutics PLC LON:AREC has signed an additional agreement with an existing client to develop a new ready-to-use RTU product formulation for a previously intravenous product. The formulation study agreement is with Par Sterile Products, part of US company Endo International PLC NASDAQ:ENDP, which will fund the development work. 